Key points are not available for this paper at this time.
Editorial on cardiac arrest subtypes; leaves open whether tailored strategies improve outcomes in prospective studies.
Department of Medicine, Section of Cardiology, Clinical Cardiac Electrophysiology Service, Rush University Medical Center, Chicago, IL Dr. Richard G. Trohman received honoraria/speaking fees from Boston Scientific; received grants from Boston Scientific, Medtronic, and St. Jude; is a member of the Advisory Board for Guidant CRM Business Strategy; is a member of the Scientific Advisory Board CH Bard; is on the speakers bureau for Guidant CRM, Medtronic, and St. Jude; is a product consultant for Biosense Webster; is a product planning consultant for Medtronic; is an investigator for products sponsored by Guidant CRM, Medtronic, St. Jude, and Viatron. Mr. Samuel D. Trohman has not disclosed any potential conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Trohman et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: